Loading...
XHKG3839
Market cap48mUSD
Jan 03, Last price  
1.57HKD
1D
1.29%
1Q
11.35%
Jan 2017
-29.28%
IPO
-60.05%
Name

Chia Tai Enterprises International Ltd

Chart & Performance

D1W1MN
XHKG:3839 chart
P/E
19.03
P/S
0.28
EPS
0.01
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
13.26%
Revenues
174m
+9.26%
132,274,000122,219,000117,131,000101,767,00087,276,00074,466,00093,362,000105,042,00093,577,000142,407,000159,239,000173,979,000
Net income
3m
P
17,714,00027,790,00019,430,0008,182,0008,058,00016,347,00021,164,00015,800,00016,255,00026,696,000-4,259,0002,553,000
CFO
-16m
L
15,747,000-3,687,00016,882,0009,870,00019,303,000-1,593,00016,571,000-7,340,0004,034,000-10,911,0005,629,000-16,062,000
Earnings
Jun 05, 2025

Profile

Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
URL
http://www.ctei.com.hk/
IPO date
Jul 03, 2015
Employees
1,000
Domiciled in
HK
Incorporated in
BM

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
173,979
9.26%
159,239
11.82%
Cost of revenue
178,514
154,359
Unusual Expense (Income)
NOPBT
(4,535)
4,880
NOPBT Margin
3.06%
Operating Taxes
1,057
1,510
Tax Rate
30.94%
NOPAT
(5,592)
3,370
Net income
2,553
-159.94%
(4,259)
-115.95%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
58,118
36,844
Long-term debt
20,050
12,258
Deferred revenue
1,648
2,170
Other long-term liabilities
Net debt
(80,238)
(103,759)
Cash flow
Cash from operating activities
(16,062)
5,629
CAPEX
(11,112)
(16,005)
Cash from investing activities
(7,140)
(15,637)
Cash from financing activities
30,225
10,385
FCF
(28,464)
4,671
Balance
Cash
37,606
30,859
Long term investments
120,800
122,002
Excess cash
149,707
144,899
Stockholders' equity
47,660
50,235
Invested Capital
284,174
252,792
ROIC
1.30%
ROCE
1.59%
EV
Common stock shares outstanding
253,329
253,329
Price
0.95
46.15%
0.65
-52.90%
Market cap
240,663
46.15%
164,664
-52.90%
EV
184,013
87,068
EBITDA
1,856
11,805
EV/EBITDA
99.14
7.38
Interest
1,954
994
Interest/NOPBT
20.37%